2019
DOI: 10.1097/iio.0000000000000298
|View full text |Cite
|
Sign up to set email alerts
|

A(eye): A Review of Current Applications of Artificial Intelligence and Machine Learning in Ophthalmology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
48
0
5

Year Published

2020
2020
2022
2022

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 55 publications
(53 citation statements)
references
References 61 publications
0
48
0
5
Order By: Relevance
“…The patient and ophthalmologist are notified if there has been a significant change in testing. 3,20,21 In a randomized, controlled clinical trial comparing 763 patients who received athome device monitoring and 757 patients who received standard care using an Amsler grid and other standard screening guidelines, researchers found that patients in the device arm lost a median of 4 letters from baseline to CNV detection while those in the standard care group lost a median of 9 letters. 21 Tele-ophthalmology is not limited to retinal disease.…”
Section: Disease-specific Tele-ophthalmologymentioning
confidence: 99%
See 4 more Smart Citations
“…The patient and ophthalmologist are notified if there has been a significant change in testing. 3,20,21 In a randomized, controlled clinical trial comparing 763 patients who received athome device monitoring and 757 patients who received standard care using an Amsler grid and other standard screening guidelines, researchers found that patients in the device arm lost a median of 4 letters from baseline to CNV detection while those in the standard care group lost a median of 9 letters. 21 Tele-ophthalmology is not limited to retinal disease.…”
Section: Disease-specific Tele-ophthalmologymentioning
confidence: 99%
“…This is often reliant on machine learning that uses computer algorithms based on large datasets and allows the machine to subsequently alter its own coding in order to make better predictions about the future. 3 IDx-DR (IDX, LLC, Coralville, Iowa, USA) received Breakthrough Device Designation and was approved by the FDA in April 2018 as the first fully autonomous, artificial intelligence enabled screening device for diagnosing eye pathology. 3 Using artificial intelligence, the IDx-DR software analyzes retinal images taken with the Topcon-NW400 in the primary care setting and determines if "more than mild diabetic retinopathy" is present, therefore prompting referral to an ophthalmologist.…”
Section: Artificial Intelligencementioning
confidence: 99%
See 3 more Smart Citations